Omeros (OMER) Total Current Liabilities (2010 - 2026)

Omeros (OMER) posted Total Current Liabilities of $59.4 million for Q1 2026, down 23.85% sequentially from $78.1 million in Q4 2025, and down 28.57% YoY from $83.2 million in Q1 2025.

Omeros (OMER) Total Current Liabilities (2010 - 2026) Analysis & Trends

Omeros has reported Total Current Liabilities for 17 years, with the latest figure at $59.4 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 28.57% year-over-year to $59.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.4 million (down 28.57% YoY) and the FY2025 annual result came in at $78.1 million, down 1.84% from the prior year.
  • Total Current Liabilities slipped to $59.4 million in Q1 2026 per OMER's latest filing, from $78.1 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $147.2 million in Q3 2023 and troughed at $35.1 million in Q1 2022.
  • A 5-year average of $80.8 million and a median of $78.1 million in 2025 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities soared 296.94% in 2023, then slumped 62.21% in 2024.
  • Over 5 years, Total Current Liabilities stood at $136.4 million in 2022, then tumbled by 60.91% to $53.3 million in 2023, then surged by 49.16% to $79.5 million in 2024, then slipped by 1.84% to $78.1 million in 2025, then retreated by 23.85% to $59.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $59.4 million, $78.1 million, and $80.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Omeros 1.24 Bn 1.24 Bn 27.73 Mn 94.96 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 94.96 Mn
Mar 31, 2026 59.44 Mn
Dec 31, 2025 78.06 Mn
Sep 30, 2025 80.76 Mn
Jun 30, 2025 85.50 Mn
Mar 31, 2025 83.22 Mn
Dec 31, 2024 79.53 Mn
Sep 30, 2024 55.62 Mn
Jun 30, 2024 59.48 Mn
Mar 31, 2024 59.06 Mn
Dec 31, 2023 53.32 Mn
Sep 30, 2023 147.18 Mn
Jun 30, 2023 143.54 Mn
Mar 31, 2023 139.19 Mn
Dec 31, 2022 136.38 Mn
Sep 30, 2022 39.51 Mn
Jun 30, 2022 38.50 Mn
Mar 31, 2022 35.07 Mn
Dec 31, 2021 51.79 Mn
Sep 30, 2021 42.82 Mn